Table 2 Cohort characteristics of patients treated with RFA
Patients (total n = 109) | ||
Age | Years | ± SD |
Mean | 63.5 | ± 11.6 |
Sex | No. of patients | % |
Male | 79 | 72.5 |
Female | 30 | 27.5 |
Primary diagnoses (total n = 109) | ||
Colorectal carcinoma | 72 | 66.1% |
Melanoma | 14 | 12.8% |
Breast carcinoma | 8 | 7.3% |
Neuroendocrine tumours (NET) | 5 | 4.6% |
Bronchial carcinoma | 1 | 0.9% |
Urothelium carcinoma | 1 | 0.9% |
Renal carcinoma | 2 | 1.8% |
Gastric carcinoma | 2 | 1.8% |
Pancreatic carcinoma | 1 | 0.9% |
Gallbladder carcinoma | 2 | 1.8% |
Hypopharyngeal carcinoma | 1 | 0.9% |
Diameter of 244 treated liver metastases | ||
Mean | 20.1 mm | ± SD 10.0 |
< 3 cm | 202 | 82.8% |
≥ 3 cm | 42 | 17.2% |
Localisation of liver metastases | ||
Segment II | 19 | 7.8% |
Segment III | 15 | 6.1% |
Segment IV | 54 | 22.1% |
Segment V | 28 | 11.5% |
Segment VI | 55 | 22.5% |
Segment VII | 33 | 13.5% |
Segment VIII | 40 | 16.4% |
Number of RFA treated lesions per patient | ||
1 lesion | 54 patients | 45.5% |
2 lesions | 26 patients | 23.9% |
3 lesions | 8 patients | 7.3% |
4 lesions | 9 patients | 8.3% |
5 lesions | 5 patients | 4.6% |
6 lesions | 2 patients | 1.8% |
7 lesions | 2 patients | 1.8% |
9 lesions | 3 patients | 2.8% |